
A newly approved implant appears to slow vision loss from a rare and previously untreatable eye disease, researchers report. The eye implant, called ENCELTO, gradually releases proteins that protect light-sensing nerve cells against macular telangiectasia (MacTel) type 2, researchers recently reported in the journal NEJM Evidence. The capsule-sized implant slowed the progression of MacTel in… read on > read on >